Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders

   
   

The present invention provides compounds, which, are novel antagonists for D.sub.1/D.sub.5 receptors as well as methods for preparing such compounds. In another embodiment, the invention provides pharmaceutical compositions comprising such D.sub.1/D.sub.5 receptor antagonists as well as methods of using them to treat CNS disorders, obesity, metabolic disorders, eating disorders such as hyperphagia, and diabetes.

A invenção atual fornece os compostos, que, são antagonistas da novela para os receptors D.sub.1/D.sub.5 as.well.as métodos para preparar tais compostos. Em uma outra incorporação, a invenção fornece as composições pharmaceutical que compreendem tais antagonistas do receptor D.sub.1/D.sub.5 as.well.as métodos de usá-los tratar disorders do CNS, obesity, disorders metabolic, comendo disorders tais como o hyperphagia, e diabetes.

 
Web www.patentalert.com

< Gssp4 polynucleotides and polypeptides and uses thereof

< Beta3 adrenergic receptor agonists and uses thereof

> Dipeptidyl peptidase inhibitors

> Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity

~ 00172